Is the future of cervical cancer screening non-invasive? Sharmila Manjeshwar, Ph.D. and Jeffrey Klausner M.D. MPH, discuss a breakthrough in HPV diagnostics: urine-based testing. While vaccination and clinical screening have reduced cervical cancer rates, participation has stalled due to barriers like healthcare access and the invasive nature of traditional clinician-collected samples. This conversation explores how novel high-volume urine concentration technology is changing the landscape, making screening more accessible, private, and efficient.
Subscribe to Editors in Conversation on , , , or and never miss an episode.
Guests:
- Sharmila Manjeshwar, Ph.D.
- Jeffrey Klausner M.D. MPH
Links:
This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Romney Humphries, Ph.D., D(ABMM) and Elitza (Elli) Theel, Ph.D., D(ABMM).
Visit to read articles and/or submit a manuscript.
Become an 91麻豆天美 member to receive up to 50% off publishing fees when you publish in JCM or any of the 91麻豆天美 journals. Sign up at asm.org/joinasm.